Background: Anthropogenic climate change presents a major global health threat. However, the very provision of healthcare itself is associated with a significant environmental impact. Carbon footprinting techniques are increasingly used outside of the healthcare sector to assess greenhouse gas emissions and inform strategies to reduce them. Aim: This study represents the first assessment of the carbon footprint of an individual specialty service to include both direct and indirect emissions. Methods: This was a component analysis study. Activity data were collected for building energy use, travel and procurement. Established emissions factors were applied to reconcile this data to carbon dioxide equivalents (CO 2 eq) per year. Results: The Dorset Renal Service has a carbon footprint of 3006 tonnes CO 2 eq per annum, of which 381 tonnes CO 2 eq (13% of overall emissions) result from building energy use, 462 tonnes CO 2 eq from travel (15%) and 2163 tonnes CO 2 eq (72%) from procurement. The contributions of the major
Introduction
Anthropogenic climate change, driven by greenhouse gas (GHG) emissions resulting from human activity, presents a major global health threat. 1, 2 However, the provision of healthcare itself is associated with significant GHG emissions. 3 Strategies to mitigate these emissions are therefore required, and reductions are also anticipated to deliver public health co-benefits and to allow organizations opportunities to exhibit good corporate citizenship. 2, 4, 5 Meanwhile, the recent introduction of carbon trading via the Carbon Reduction Commitment Energy Efficiency Scheme, 6 the inclusion of sustainability within the Audit Commission's annual performance assessments, 7 and the uptake of carbon efficiency as a local indicator by commissioners and providers, 8 mean that the quest for carbon reduction is not only an increasingly real pressure on NHS organizations but also a timely driver for financial savings.
The NHS Carbon Reduction Strategy sets targets for GHG emissions within the NHS; using 2007 levels as the baseline, the strategy requires an 80% reduction before 2050 and a 34% reduction as early as 2020. 9 These are challenging targets which will only be achieved by fully understanding the GHG emissions associated with the delivery of healthcare. While the GHG emissions associated with NHS England and individual aspects of healthcare services, procedures and trials are discussed in the literature, 3, [10] [11] [12] this study represents the first assessment of the carbon footprint of an individual specialty to include both direct and indirect emissions. The primary aim of this study was to calculate the carbon footprint of the Dorset Renal Service, thereby providing an evidence base for future decision-making by highlighting the areas of a renal service with the greatest carbon footprint. The secondary aims were to calculate the carbon footprints of both an outpatient appointment and an inpatient bed day, in order to facilitate modelling of alternative pathways of care and to provide a template by which other services might ascertain their own carbon footprints.
Methods
This study calculates GHG emissions for the Dorset Renal Service for the period 1 April 2008 to 31 March 2009. The Dorset Renal Service covers a geographical area of $1300 square miles and a population of 865 000. The six component services of the Dorset Renal Service are inpatient care, outpatient care, peritoneal dialysis, haemodialysis (in-centre and home), transplantation and administration. These are provided across five geographically separate sites (Dorset County Hospital Dorchester, DCH; Yeovil District Hospital, YDH; Poole General Hospital, PGH; Royal Bournemouth Hospital, RBH; and Southmead Hospital in Bristol, SMH). Inpatient care is provided in a 14 bed ward (DCH). Outpatient care is provided through the seven clinics held each week across four sites (DCH, RBH, PGH, YDH), with less frequent clinics held by the nurse-led pre-dialysis and anaemia teams and transplantation Specialist Nurses (who also undertake home visits). Haemodialysis was being provided to 225 patients across four sites (55 at DCH, 60 at RBH, 63 at PGH, 45 at YDH) with two patients undertaking home therapy, while peritoneal dialysis was being provided from two centres to 54 patients (15 from DCH, 39 from RBH). Patients receiving renal transplants have their investigative work-up undertaken at the hospital local to their clinic. Transplantation surgery is performed at a tertiary centre (SMH). After discharge, patients remain under outpatient follow up at the tertiary centre for an average of three weeks prior to referral back to their local clinic. Further surgery integral to the care provided by the Dorset Renal Service (dialysis access surgery, parathyroidectomy) is primarily undertaken at DCH, with those patients requiring inpatient stays being managed on the renal inpatient ward. A small amount of day-case dialysis access surgery is undertaken at RBH. Administrative work is undertaken primarily at DCH.
Emissions terminology
The Kyoto Protocol identifies multiple gases with global warming potential although only three are commonly reported [carbon dioxide (CO 2 ), methane (CH 4 ), nitrous oxide (N 2 O)].
13 CO 2 is most commonly used as the reference gas, with the emissions of the other gases being expressed in the units of CO 2 equivalents (CO 2 eq). This study reports the total emissions in tonnes of CO 2 eq per year.
Approach
This was a component analysis, in which activity data were collected from the component services across the different sites and summated to calculate the carbon footprint. A process analysis, or 'bottom up', approach was adopted to collate the data relating to the sectors of building energy use, travel, waste and water use. These data were physical in nature. The procurement data were collected predominantly through a 'top down' approach (e.g. pharmaceutical and medical equipment data) and complemented by data collected using a 'bottom up' approach where possible (e.g. construction). This data included both economic and physical components.
Emissions have been calculated on a consumption basis, and are the sum of three primary sectors: direct emissions from building energy use (heating, cooling, hot water and electricity consumption); direct emissions from the travel of patients, visitors and staff; and indirect procurement emissions. Procurement emissions can be defined as the embodied emissions associated with the production, consumption and disposal of all goods and services either consumed within the Dorset Renal Service or arising in the industrial supply and disposal chains.
Established emissions factors were applied to reconcile the activity data from the different sources to a single unit of measurement for GHG emissions (CO 2 eq). This report adheres to the principles and definitions defined within the Publicly Available Specification for the measurement of GHG emissions from goods and services (PAS2050).
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Assumptions and data sources
It was necessary to make a number of informed assumptions during the undertaking of this study and the contexts of those assumptions are outlined here. The activity data (the materials and energy involved in a service or product) were almost exclusively primary data (determined by direct measurements made within the service). The two exceptions were waste, which was estimated from a combination of primary and secondary data and building energy use, for which secondary data relating to the hospitals, rather than the service components of the Dorset Renal Service within them, were collected.
Building energy use data. Building energy use at the different sites was calculated from data submitted to the national Estates Return Information Collection database and is based upon the proportion of floor space occupied by the Dorset Renal Service at its different sites.
Travel and transport data. 'Travel' is defined as the movement of people and 'transport' as the movement of goods. Data relating to patient travel (including outpatient appointments, inpatient admissions, dialysis treatments and pathology investigations) and staff travel (both business and commuting) were derived from travel surveys. The data collected included the distances and modalities of travel used (active travel, car, bus, train and air). These data were extrapolated up to represent annual data. Data regarding the distances travelled by patients attending radiological investigations and day-case treatments were sourced from computerized departmental records and assumptions were made regarding the modes of travel used (based on the distances and data from the National Transport Survey 2006). 15 Data regarding distance and mode of visitor travel were estimated from the National Transport Survey 2006. 15 It was assumed that only inpatients received visitors, and that each inpatient would receive one visitor every other day. It was assumed that each visitor undertook a 25-mile round trip reflecting the geographical region covered by the inpatient ward. Assumptions were made regarding the mode of travel (based on the distances and data from the National Transport Survey 2006).
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Procurement data. Expenditure data for pharmaceuticals, medical equipment, paper, food, sanitation products and information technology were collected from the relevant departments and deflated to 2004 values; this was necessary as the conversion factors for supply chain emissions were produced from economic input-output tables using 2004 prices. 3, 16 The numbers of radiological and pathological investigations were determined from computerized departmental records. The volume of water used to provide haemodialysis was determined from meter readings at DCH and estimated for other sites. The weight of linen sent to laundry was determined from measurements of the linen generated by individual patient activities. The distance that linen was transported to the private laundry companies was determined using GoogleMaps. Assumptions were made regarding the mode of this transport and regarding the energy consumption of the washing and drying machines used.
Waste was categorized as either clinical or domestic. While the vast majority of clinical waste undergoes incineration, assumptions regarding the proportions of domestic waste being incinerated, recycled or sent to landfill were made from published data. 16 Secondary data, in the form of the weights of these different types of waste produced by the different component services, were estimated from published reports. 17, [18] [19] [20] It was assumed that emissions resulting from the disposal to landfill of any ash from incineration would be negligible and that no energy recovery would be feasible from incineration.
Boundary Setting
Inclusions
Emissions arising from the primary sectors of building energy use, travel and procurement were included, and the impact of every identifiable staff member was considered. Although PAS2050 demands that the boundary of the service should exclude emissions associated with the travel of employees to and from their normal place of work, and of consumers (in this case, patients) to and from their point of service use, 14 this study includes such travel activity in order to maintain consistency with the NHS England Carbon Footprinting Study.
Inter-departmental overlap of resource use. The provision of healthcare involves considerable overlap between different clinical services. For example, a patient whose care is primarily delivered by the Dorset Renal Service may also undergo diagnostic investigations performed by a local Radiology Service. Those aspects of such secondary services that are directly attributable to the care provided to patients from the Dorset Renal Service have been included.
Dialysis access surgery, parathyroidectomy and renal transplantation are integral to the care provided by the Dorset Renal Service. Emissions relating directly to these surgical procedures (e.g. building energy use and procurement of equipment and pharmaceuticals), to the peri-operative care of the patients, and to associated travel, were therefore considered to lie within the carbon footprint of the Dorset Renal Service.
Universal exclusions
To maintain consistency with PAS2050, 14 the following sources of GHG emissions were considered to lie outside of the study: the capital cost of machinery; buildings; human inputs into the processes; food and beverages for staff; scientific research into renal medicine; staff training; water use other than that used in haemodialysis; business services; and immaterial emissions sources (those anticipated to be <1% of total footprint).
Emissions factors
The choice of emissions factors
Only two emissions conversion factors were identified for pharmaceuticals and medical equipment and these displayed considerable variation (Table 1) . 3, 16 An analysis of the carbon footprint, calculated from the weights and primary constituent materials of the items procured, of a sub-group of the medical equipment procured by the Dorset Renal Service indicated that the emissions factors produced by DEFRA most accurately reflect the emissions attributable to the medical equipment used by the Dorset Renal Service. These emissions factors were also found to correlate very closely with the only identified example of a carbon footprint calculated for an individual product comparable in nature to those used in kidney care (the Viaflo Õ , produced by Baxter Healthcare, information by personal communication). As the subsector of pharmaceuticals does not lend itself to a similar assessment of the available emissions factors, we have used the DEFRA emissions factors for the purposes of consistency.
Emission factors used in this study
The emissions factors applied to activity data for building energy use, travel and transport, procurement are provided in Tables 2-5 .
Emissions factors for building energy use.
Emissions factors for travel and transport.
Emissions factors for procurement. In the absence of specific data, it was assumed that the emissions attributable to a radiological investigation were 0.1 kg CO 2 eq (a relatively small value intended to reflect the small amount of materials Emissions factors for waste. Our model assigns the carbon embedded in products to their manufacture and it is therefore included within the emissions attributable to their procurement. To avoid 'double counting' this carbon, the 'end of life' carbon footprint has been calculated using the DEFRA emissions factors for waste treatment processes, 16 as opposed to the sum of the 'end of life' and 'production' carbon footprints.
Since the recycling of domestic waste is not undertaken within the Dorset Renal Service, the carbon recovered is realized outside of the boundary of this study. However, we have elected to apply the DEFRA emissions factors for recycling to this waste (rather than to consider the disposal of this waste to have no impact upon the overall carbon footprint of the Dorset Renal Service) in order to maintain consistency in our approach to waste management.
Results
The carbon footprint of the dorset renal service
Primary sector results
The carbon footprint of the Dorset Renal Service was 3007 tonnes CO 2 eq. The contributions of the primary sectors are displayed in Figure 1 . b DEFRA emissions factors for incineration do not specifically account for clinical waste, which is commonly undertaken at higher temperatures. To reflect the increased emissions that are likely to result from the incineration of clinical waste, the highest available emissions factor for incineration was applied to each of the constituents. 
Sub-sector results
The calculated emissions of the sub-sectors are given in Table 6 and displayed in Figures 2 and 3 .
Carbon emissions per unit of healthcare activity 
Discussion
The carbon footprint of the Dorset Renal Service
The total GHG emissions of the Dorset Renal Service in 2008 are 3007 tonnes CO 2 eq. Supply chain emissions are responsible for 72% of these. The increased contribution of the pharmaceutical subsector (35%) compared to its contribution to the carbon footprint of NHS England (21%) reflects, in part, the polypharmacy commonly experienced by patients with kidney disease, and would have been greater still had the medications originally commenced by the Dorset Renal Service but subsequently provided by Primary Care also been included. 3 The significant contribution attributable to medical equipment (25%) reflects the role that single-use, pre-packaged products have played in facilitating the increasing availability of dialysis and is further evident in the contribution of waste to the overall emissions (10% compared with 3% within NHS England). 3 Although carbon-reduction strategies often focus on building energy use, this contributes only 13% of the overall emissions-considerably <22% contribution made by building energy use to the NHS England carbon footprint. 3 This discrepancy is probably the result of two factors. First, while the overall building energy use attributable to business services was accounted for in the NHS England study, we excluded from our study the proportion of building energy use attributable to the hospital business services that might reasonably have been allocated to the carbon footprint of the Dorset Renal Service (as it was not quantifiable). Second, the considerable amount of emissions resulting from the procurement sector will have impacted upon the balance of the contributions of the different primary sectors with the carbon footprint of the Dorset Renal Service. Overall, the results of this study support the assertion that measures to reduce building energy use, although important, should form only part of strategies intended to reduce the carbon footprint of renal services. 22 Similarly, even with the inclusion of staff commuting travel, overall travel emissions contribute only 15% of the carbon footprint of the Dorset Renal Service. Patient travel contributes 60% of the overall travel emissions. That this is greater than the contribution made by patient travel to the overall travel emissions of NHS England (44%) is not unexpected given that the most common form of renal replacement therapy, in-centre haemodialysis, 23 requires that patients undertake return journeys to their dialysis facility three times per week. However, this discrepancy is lessened by the provision of dialysis at satellite units, which reduce patient travel within renal services. In this regard, the Dorset Renal Service is typical in that it has three such units (the mean number of satellite units per hub unit in England is 3.02, range 0-10, calculated using data from the 12th Annual Renal Registry Report 23 ). The contribution of dialysis-related patient travel is of interest. While patient travel to haemodialysis is responsible for 173 tonnes of CO 2 eq, representing 34% of overall travel emissions, this amounts to only 6% of the overall emissions of the Dorset Renal Service. Given that the Dorset Renal Service provides in-centre haemodialysis in a relatively rural population, and to a higher than average proportion of the patients requiring renal replacement therapy (49.8%, compared to a mean within England of 39.6%, range = 7.2-72.2%, calculated using data from the 12th Annual Renal Registry Report 23 ), these results indicate that, while necessary, initiatives to reduce the emissions associated with dialysis-related patient travel are unlikely to impact significantly upon the overall carbon footprint of renal services.
Carbon emissions per unit of healthcare activity
But is renal medicine a carbon intensive specialty? The 21.3 million tonnes of emissions attributed to NHS England result from the provision of care to 51.4 million people (0.4 tonnes per patient per year). 3 Data regarding the proportion of the population of England accessing renal services are not available, and neither are similar data for the population covered by the Dorset Renal Service. However, data from the UK Renal Registry confirms that the proportion of the population of England receiving either haemodialysis or peritoneal dialysis is extremely small (0.04%). 23 Yet, it is to be expected that the provision of these two forms of renal replacement therapy will contribute significantly to the emissions arising from a renal service, and, indeed, these two components of the Dorset Renal Service contribute 65.4% of its overall carbon footprint ( Table 7) . The provision of haemodialysis and peritoneal dialysis to just 277 patients, from a population of 865 000, results in 1965 tonnes of CO 2 eq, equating to 7.1 tonnes of CO 2 eq per dialysis patient per year. Therefore, just as kidney care is considered to be a 'high cost, low volume' specialty in financial terms, it seems likely that it is also a carbon intensive specialty when considered in terms of the numbers of patients treated with renal replacement therapy.
This line of thinking is supported by our finding that a total of 824 of the 3007 tonnes of CO 2 eq attributable to the Dorset Renal Service result from the provision of an estimated 5110 inpatient bed days per year, equating to GHG emissions of 161 kg CO 2 eq per bed day (Table 9 ). This estimate is considerably higher than the only other published figure of this nature; a recent top-down study by the NHS Sustainable Development Unit (SDU) estimated the GHG emissions associated with one bed day (within all clinical specialties) to be 80 kg CO 2 eq through the application of four methodologies to data from the NHS England Carbon Footprinting report. 3, 24 The discrepancy appears to be largely due to the emissions arising from the procurement of pharmaceuticals and medical equipment, and is therefore perhaps explained in part by the provision of renal replacement therapy to patients on the inpatient renal ward.
We have calculated the GHG emissions attributable to an outpatient appointment to be 22 kg CO 2 eq (Table 8 ). Given the current lack of carbon footprinting studies within healthcare, it is noteworthy that this estimation, produced by a 'bottom-up' approach, is comparable in magnitude to that of the only other published data, again from the 'top-down' NHS SDU study, 24 which applied three methodologies to data from the NHS England Carbon Footprinting report, 3 and reported estimations of 24, 38 and 78 kg CO 2 eq per outpatient appointment. The figure reported here lies at the lower end of this range, perhaps reflecting the exclusion of pharmaceuticals prescribed from primary care.
Limitations
While prospective collection of primary activity data would perhaps provide a more accurate carbon footprint, such an approach would be resource and time intensive and would not be easily transferable to other services. There are two other limitations to the technique of carbon footprinting relevant to this study. First, it should be appreciated that a carbon footprint does not provide a complete assessment of the environmental impact of a service or product. For example, although water is a finite natural resource, the 22 million litres of water used annually by the Dorset Renal Service for haemodialysis alone result in <1% of its GHG emissions.
The second limitation relates to the evaluation of uncertainty within the results. The two main approaches to carbon footprinting, process analysis and input-output assessments, have differing uncertainty profiles, and their use in isolation can present difficulties in interpreting these profiles. 25 Within this study, the extent of any truncation error, occurring as a result of the exclusion of components of the service or product within the process analysis approach (as was used in this study), cannot easily be estimated without applying a concurrent inputoutput approach (termed a 'hybrid life cycle analysis', which was not feasible in this study). Furthermore, although we undertook measures to identify the most appropriate emissions factors for this study, the considerable variation between emissions factors quoted by different sources for the medical equipment and pharmaceutical supply chains, and the extent to which these subsectors contribute to the carbon footprint, means that uncertainty is conveyed to our final results.
Recommendations
The implementation of carbon-reduction strategies should be informed by economic analyses, enabling the prioritization of those initiatives proven to be either cost-effective or, indeed, cost-saving. Within renal medicine, cost-effective carbon-reduction strategies already exist, for example, within the practice of waste management and the use of building energy and water. [26] [27] [28] However, where possible, carbon-reduction strategies should also target those areas of the provision of healthcare that are associated with the greatest burden of emissions. Within a renal service, this study indicates that measures to reduce the emissions arising from the procurement of pharmaceuticals and medical equipment are of particular importance. Such measures might take a number of forms, including: strategies to improve patient compliance with, and reduce wastage of, pharmaceuticals; exploration of opportunities to re-use medical equipment through re-evaluation of the extent to which risk management defines infection control policies; and the adoption of sustainable procurement policies. The elimination of ineffective, or 'low value', treatments and models of care from clinical practice will lower healthcare-related emissions while also improving clinical care, and should therefore be prioritized. Healthcare research has an important role to play in ensuring that only safe and effective healthcare is provided; the carbon footprint of the clinical trials required to determine reliable information is significant, 10 but is likely to be far less than that of the ineffective treatments, technologies and models of care that may persist in the absence of such trials.
We, therefore, propose that a transformation to lower carbon clinical care is required. The NHS Next Stage review identified that improvements in the quality of care will require service change and innovation, 29 presenting an opportunity to introduce lower carbon clinical care pathways. The estimated GHG emissions identified for outpatient appointments and inpatient admissions calculated here and in previous studies 23 may be of value in modelling lower carbon pathways of care, but further research, including carbon footprinting studies, is required to better understand the environmental impacts of healthcare technologies, treatments and models of care. This will necessitate the generation of more specific healthcare-related emissions factors, particularly with respect to the medical equipment and pharmaceutical sub-sectors.
A second requirement is improved accessibility to high quality primary activity data in order to increase the accuracy and ease of completion of further carbon footprinting studies. This might be achieved through simple measures such as sub-metering of electricity consumption in renal units, improved waste auditing and the use of more refined procurement data recording systems.
Conclusions
This study has calculated the carbon footprint of the Dorset Renal Service. The contributions of the three primary sectors (travel, building energy use and procurement) and their subsectors have been identified, and the emissions associated with different healthcare activities have been estimated. The methodology employed in this study can be translated to other renal services and might be used to inform similar studies in other specialties. The results support the proposal that a clinical transformation is required if the carbon-reduction targets identified for the NHS are to be met within renal services, and might be used to inform the necessary carbon-reduction strategies. The variation in the contributions of the different sectors to the carbon footprints of a renal service and the NHS indicate that carbon-reduction strategies should be tailored to individual specialties.
